• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢匹罗在儿科的实验室及临床研究

[Laboratory and clinical studies on cefpirome in pediatrics].

作者信息

Nagano K, Nakayama N, Tuji Y, Miyazoe H

机构信息

Department of Pediatrics, Nagasaki Central National Hospital.

出版信息

Jpn J Antibiot. 1991 May;44(5):543-51.

PMID:1880934
Abstract

Laboratory and clinical studies on cefpirome (CPR, HR 810), a newly developed cephem antibiotic, were performed. The results obtained are summarized as follows: 1. Absorption and elimination of the drug were examined in a total of 7 children including 3 cases of administered with 20 mg/kg intravenous bolus injection (i.v.), 2 cases with 20 mg/kg drip infusion (d.i.v.) for 60 minutes and 2 cases with 40 mg/kg (d.i.v.) for 60 minutes. Maximum serum levels were attained immediately after i.v. or d.i.v. Cmax's were 233 +/- 7.6, 88.5 +/- 14.5, and 116 +/- 15 micrograms/ml, respectively for the above 3 modes of administration. These values were determined using a bioassay method with Bacillus subtilis ATCC 6633. T 1/2 (beta)'s were 1.18 +/- 0.17, 1.61 +/- 0.28 and 2.68 +/- 0.83 hours, respectively. Cumulative urinary recovery rates were 40.2-69.8% in a period of 0-6 hours after admissions. 2. Clinical efficacies were evaluated in a total of 20 patients with ages ranging from 9 months to 11 years. The treated cases were 6 cases of acute pneumonia, 4 cases of acute bronchitis, 4 cases of acute purulent tonsillitis, 2 cases of acute urinary tract infections, 2 cases of cellulitis, 1 case of purulent lympadenitis and 1 case of acute otitis media. The clinical efficacy rate was 94.7%. Adverse reactions occurred in no patients. Abnormal changes in laboratory test values involved only 1 case with elevated GOT and GPT. CPR was considered to be a safe and useful drug in treating various infectious diseases in children.

摘要

对新开发的头孢匹罗(CPR,HR 810)进行了实验室和临床研究。所得结果总结如下:1. 对总共7名儿童进行了药物吸收和消除研究,其中3例静脉推注20mg/kg,2例静脉滴注20mg/kg持续60分钟,2例静脉滴注40mg/kg持续60分钟。静脉推注或静脉滴注后立即达到最高血清水平。上述3种给药方式的Cmax分别为233±7.6、88.5±14.5和116±15μg/ml。这些值是使用枯草芽孢杆菌ATCC 6633的生物测定法测定的。T 1/2(β)分别为1.18±0.17、1.61±0.28和2.68±0.83小时。入院后0至6小时内累积尿回收率为40.2 - 69.8%。2. 对总共20名年龄在9个月至11岁之间的患者进行了临床疗效评估。治疗病例包括6例急性肺炎、4例急性支气管炎、4例急性化脓性扁桃体炎、2例急性尿路感染、2例蜂窝织炎、1例化脓性淋巴结炎和1例急性中耳炎。临床有效率为94.7%。无患者出现不良反应。实验室检查值异常仅涉及1例GOT和GPT升高。头孢匹罗被认为是治疗儿童各种传染病的一种安全有效的药物。

相似文献

1
[Laboratory and clinical studies on cefpirome in pediatrics].头孢匹罗在儿科的实验室及临床研究
Jpn J Antibiot. 1991 May;44(5):543-51.
2
[Laboratory and clinical studies on cefpirome in pediatrics].
Jpn J Antibiot. 1991 Jul;44(7):748-69.
3
[Laboratory and clinical studies on cefodizime in the pediatric field].头孢地嗪在儿科领域的实验室及临床研究
Jpn J Antibiot. 1989 Jun;42(6):1424-35.
4
[Fundamental and clinical studies of ceftazidime in the pediatric field].
Jpn J Antibiot. 1984 Mar;37(3):537-53.
5
[Pharmacokinetic and clinical evaluation of cefpirome in the pediatric field].
Jpn J Antibiot. 1991 Apr;44(4):426-39.
6
[Pharmacokinetics and clinical studies of flomoxef in the pediatric field].
Jpn J Antibiot. 1987 Aug;40(8):1515-34.
7
[Pharmacokinetic and clinical evaluation of cefozopran in the pediatric field].
Jpn J Antibiot. 1994 Nov;47(11):1521-35.
8
[Pharmacokinetic and clinical evaluation of cefpirome in the pediatric field].
Jpn J Antibiot. 1991 Feb;44(2):184-206.
9
[Laboratory and clinical studies on ceftazidime in the field of pediatrics].头孢他啶在儿科领域的实验室及临床研究
Jpn J Antibiot. 1984 Mar;37(3):469-84.
10
[Bacteriological, pharmacokinetic and clinical evaluations of cefpirome sulfate in the pediatric field. Pediatric Study Group of Cefpirome].
Jpn J Antibiot. 1991 Jan;44(1):84-109.